Caldwell Sutter Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.13M Sell
9,394
-75
-0.8% -$8.66K 0.46% 53
2025
Q4
$997K Buy
9,469
+211
+2% +$19.8K 0.42% 62
2025
Q3
$777K Buy
9,258
+2,035
+28% +$168K 0.33% 82
2025
Q2
$572K Buy
7,223
+330
+5% +$26.2K 0.26% 103
2025
Q1
$619K Buy
6,893
+374
+6% +$34.9K 0.29% 92
2024
Q4
$649K Buy
6,519
+87
+1% +$8.97K 0.3% 89
2024
Q3
$730K Sell
6,432
-1,343
-17% -$160K 0.34% 79
2024
Q2
$963K Sell
7,775
-628
-7% -$80.9K 0.48% 55
2024
Q1
$1.11M Sell
8,403
-338
-4% -$41.7K 0.53% 50
2023
Q4
$953K Sell
8,741
-193
-2% -$20K 0.48% 60
2023
Q3
$920K Sell
8,934
-392
-4% -$42.3K 0.51% 58
2023
Q2
$1.08M Buy
9,326
+3,466
+59% +$394K 0.56% 44
2023
Q1
$623K Buy
5,860
+2,845
+94% +$307K 0.45% 55
2022
Q4
$335K Buy
+3,015
New +$308K 0.3% 75

Other funds holding MRK

Caldwell Sutter Capital's MRK Position: Q1 2026 in Review

Caldwell Sutter Capital reduced its Merck (MRK) stake by 0.79% in Q1 2026, selling an estimated $8.66K and leaving 9,394 shares worth $1.13M. The position accounts for 0.46% of the portfolio, ranked #53.

Caldwell Sutter Capital first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Caldwell Sutter Capital held 9,394 shares of Merck worth $1.13M as of Q1 2026.
  • Caldwell Sutter Capital sold 75 Merck shares in Q1 2026, an estimated $8.66K.
  • Merck made up 0.46% of Caldwell Sutter Capital's portfolio in Q1 2026, its #53 holding.
  • Caldwell Sutter Capital first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.